Facebook Linkedin Twitter
Inside Precision Medicine In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia

Drug regulation

An illustration of a CRISPR-Cas9 gene editing protein cutting a DNA helix
News & Features

In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia

0
Prostate cancer cells
News & Features

FDA Approves First-Line Enzalutamide/Talazoparib Combo in Prostate Cancer

0
The Lab
Coronavirus

Pfizer/BioNTech COVID-19 Vaccine Poised for FDA Emergency Use Authorization

0
Scientists Loading Centrifuge
Coronavirus

Testing Conundrum

Alex Philippidis
0
Wuhan corona virus render
Coronavirus

Pfizer, BioNTech’s COVID-19 Vaccine Gains Temporary U.K. Authorization

0
Antibodies responding to covid-19 coronavirus, illustration
Coronavirus

EUA for COVID-19 Vaccine Sought by Moderna

0
Antibodies responding to COVID-19 coronavirus, illustration
Coronavirus

Regeneron’s COVID-19 Antibody “Cocktail” Granted Emergency Use Authorization by FDA

0
Asian doctor in PPE medical suit with an injection vaccine and infusion drip for covid-19 or corona virus patient
Coronavirus

Pfizer, BioNTech Apply for COVID-19 Vaccine Emergency Use Authorization

0
Picture of patient receiving a dancer drug to represent precision cancer therapies
News & Features

ASCO Advocates Value Framework to Combat High Cancer Drug Prices

0

Related Content

Sage Publishing

Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy

Sage Publishing
Inside Precision Medicine